Abstract: Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
Type:
Grant
Filed:
June 23, 1993
Date of Patent:
June 13, 1995
Assignee:
Merck Frosst Canada, Inc.
Inventors:
Rejean Fortin, Yves Girard, Erich Grimm, John Hutchinson, John Scheigetz